{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Davie",
      "state": "FL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "70849",
      "recalling_firm": "Actavis Laboratories, FL, Inc.",
      "address_1": "4955 Orange Dr",
      "address_2": "N/A",
      "postal_code": "33314-3902",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0488-2015",
      "product_description": "Cartia XT (diltiazem HCl extended-release capsules, USP), Once-A-Day Dosage, 300 mg, 90-count bottles, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA --- NDC 62037-0600-90",
      "product_quantity": "2,628 bottles",
      "reason_for_recall": "Presence of Foreign Substance; fine residue or dust identified as aluminum may be on exterior of the capsule shell",
      "recall_initiation_date": "20150326",
      "center_classification_date": "20150415",
      "termination_date": "20161230",
      "report_date": "20150422",
      "code_info": "Lot # 956000M, Exp. Aug 2016; UPC 3-6203760090-6"
    }
  ]
}